National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:
“Calling oncology founders.
Applications are now open for the 2026 AIM-HI Venture Competition.
If you are building a breakthrough cancer therapy or technology and need non-dilutive funding, strategic mentorship, and access to a global network of investors and experts, this is your opportunity.
AIM-HI was created to bridge the gap between discovery and delivery. We accelerate bold science out of the lab and toward patients.
Apply now and take the next step in transforming cancer treatment.”
Other articles featuring NFCR on OncoDaily.